Tirzepatide
Dual GIP and GLP-1 receptor agonist
Two-pathway appetite and blood sugar support, with the largest average weight loss seen in clinical trials.

What it is
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1, that help regulate appetite, fullness and blood sugar. In the SURMOUNT-1 trial, adults lost an average of 15 to 21% of their body weight over 72 weeks alongside lifestyle changes.
Tirzepatide is the active ingredient in FDA-approved prescription medications for weight management. Your physician will explain which form is right for you, and whether you qualify. You can also see an estimate of weight change with our GLP-1 projection calculator.
Potential benefits
Appetite and fullness
Helps you feel satisfied sooner and reduces food noise.
Sustained weight loss
Supports steady, long-term loss when paired with nutrition and activity.
Metabolic health
Improves blood sugar control and insulin sensitivity.
Heart health markers
Trials also showed improvements in waist size, blood pressure and lipids.
How it fits your plan
GLP-1 care at PURE always includes a physician consult, regular check-ins and practical guidance on nutrition, protein and strength training, so you lose fat while protecting muscle.
Results vary from person to person, and Tirzepatide is not right for everyone. Your free consult is where a PURE physician decides, with you, whether it suits your health and goals.
Also discussed for
weight & metabolism.
Curious about Tirzepatide? Ask a physician.
Book a free telehealth consult. A PURE physician will explain whether Tirzepatide suits your goals and health, and what to expect.